Correlation Between Travere Therapeutics and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Travere Therapeutics and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Madrigal Pharmaceuticals.
Diversification Opportunities for Travere Therapeutics and Madrigal Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Travere and Madrigal is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 7.53 times less return on investment than Madrigal Pharmaceuticals. But when comparing it to its historical volatility, Travere Therapeutics is 2.04 times less risky than Madrigal Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 21,593 in Madrigal Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 11,552 from holding Madrigal Pharmaceuticals or generate 53.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Travere Therapeutics |
| Madrigal Pharmaceuticals |
Travere Therapeutics and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Madrigal Pharmaceuticals
The main advantage of trading using opposite Travere Therapeutics and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |